-
- Firas Baidoun
- Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH,United States
-
- Kholoud Elshiwy
- Faculty of Medicine, Ain Shams University, Cairo,Egypt
-
- Yasmine Elkeraie
- High institute of Public Health, Alexandria University, Alexandria,Egypt
-
- Zahi Merjaneh
- Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH,United States
-
- George Khoudari
- Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH,United States
-
- Muhammad Talal Sarmini
- Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH,United States
-
- Mohamed Gad
- Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH,United States
-
- Muneer Al-Husseini
- Department of Medicine, Ascension St John Hospital, Detroit, Michigan,United States
-
- Anas Saad
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH,United States
説明
<jats:sec> <jats:title /> <jats:p>Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related deaths in the world with an estimated number of 1.8 million new cases and about 881,000 deaths worldwide in 2018. The epidemiology of CRC varies significantly between different regions in the world as well as between different age, gender and racial groups. Multiple factors are involved in this variation, including risk factor exposure, demographic variations in addition to genetic susceptibility and genetic mutations and their effect on the prognosis and treatment response. In this mini-review, we discuss the recent epidemiological trend including the incidence and mortality of colorectal cancer worldwide and the factors affecting these trends.</jats:p> </jats:sec>
収録刊行物
-
- Current Drug Targets
-
Current Drug Targets 22 (9), 998-1009, 2021-07
Bentham Science Publishers Ltd.
